India’s largest study validates robotic surgery for kidney tumors

New Delhi: In a recent development, Intuitive unveiled the results of a comprehensive study on robotic-assisted partial nephrectomy (RAPN) in India. This collaborative effort, conducted across 14 esteemed medical institutions, signifies a significant stride in urological care within the country.

Over the course of 12 years, researchers analyzed data from 800 cases, shedding light on the efficacy and safety of robotic surgery in treating renal masses. Dr. Sudhir Rawal, Director of Genito Uro Oncology Services at Rajiv Gandhi Cancer Institute and Research Centre, emphasized, “The study results bridge a crucial gap in our understanding of robotic-assisted partial nephrectomy outcomes in India.”

He further stated, “Our study results help fill this gap by providing insights into the efficacy and safety of robotic-assisted partial nephrectomy across diverse patient demographics and tumor complexities. This will help provide trained surgeons the confidence in choosing robotic-assisted surgery for renal masses, for better clinical outcomes.”

Swati Gupta, Marketing Director at Intuitive India, underscored, “The data demonstrates the potential of the da Vinci system in improving patient outcomes for robotic-assisted partial nephrectomy in India and lays the groundwork for further advancements in robotic surgery nationwide.”

“Collaboration with leading Indian institutions and surgeons has provided valuable insights specific to the Indian patient population. Going forward, this knowledge will be crucial in refining surgical techniques and expanding access to minimally invasive robotic surgery for more patients. We are proud to have contributed to this important research and look forward to its positive impact on patient care in India,” Gupta remarked.

The key findings from the study include favorable Perioperative outcomes, with a median operative time of 180 minutes and minimal estimated blood loss. Notably, the procedure boasted a low conversion rate to open surgery (0.4%) and manageable complication rates, predominantly minor in severity. 

Moreover, functional outcomes indicated promising postoperative stability in serum creatinine and estimated glomerular filtration rate levels, showcasing RAPN’s proficiency in preserving renal function. Achieving trifecta and pentafecta outcomes in a majority of cases underscored the procedure’s efficacy and potential to enhance patient care in India’s healthcare landscape.

“While partial nephrectomy has emerged as the preferred treatment approach for renal masses, our study supports the efficacy of using the da Vinci system in India for these procedures,” emphasized Dr. Rawal. “By establishing a comprehensive database of clinical outcomes, we aim to pave the way for further advancements in this area tailored to our population.”